medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2005, Número 2

<< Anterior Siguiente >>

Ann Hepatol 2005; 4 (2)


Molecular bases of the excretion of fetal bile acids and pigments through the fetal liver-placenta-maternal liver pathway

Marín JJG, Macías RIR , Briz O, Pérez MJ, Ángeles SM

Idioma: Ingles.
Referencias bibliográficas: 90
Paginas: 70-76
Archivo PDF: 89.42 Kb.


FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Vavricka SR, Van Montfoort J, Ha HR, Meier PJ, Fattinger K. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver. Hepatology 2002; 36(1): 164-172.

  2. Zucker SD, Goessling W. Mechanism of hepatocellular uptake of albumin-bound bilirubin. Biochim Biophys Acta 2000; 1463(2): 197-208.

  3. Ferenci P, Zollner G, Trauner M. Hepatic transport systems. J Gastroenterol Hepatol 2002; 17(Suppl): S105-S112.

  4. Hagenbuch B, Meier PJ. Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch 2004; 447(5): 653-665.

  5. Meier PJ, Stieger B. Bile salt transporters. Annu Rev Physiol 2002; 64: 635-661.

  6. Cui Y, Konig J, Leier I, Buchholz U, Keppler D. Hepatic uptake of bilirrubin and its conjugates by the human organic anion-transporting polypeptide SLC21A6. J Biol Chem 2001; 276(13): 9626-9630.

  7. Briz O, Serrano MA, Macias RI, Gonzalez-Gallego J, Marin JJG. Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8 in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin. Biochem J 2003a; 371(3): 897-905.

  8. Hagenbuch B, Stieger B, Foguet M, Lubbert H, Meier PJ. Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system. Proc Natl Acad Sci USA 1991; 88(23): 10629-10633.

  9. Boyer JL, Hagenbuch B, Ananthanarayanan M, Suchy F, Stieger B, Meier PJ. Phylogenic and ontogenic expression of hepatocellular bile acid transport. Proc Natl Acad Sci USA 1993; 90(2): 435-438.

  10. Craddock AL, Love MW, Daniel RW, Kirby LC, Walters HC, Wong MH, Dawson PA. Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol 1998; 37(1): G157-G169.

  11. St-Pierre MV, Stallmach T, Grundschober AF, Dufour J-F, Serrano MA, Marin JJG, Sugiyama Y, et al. Temporal expression profiles of organic anion transport proteins in placenta and fetal liver of the rat. Am J Physiol 2004; 287(6): R1505-R1516.

  12. Patel P, Weerasekera N, Hitchins M, Boyd CA, Johnston DG, Williamson C. Semi quantitative expression analysis of MDR3, FIC1, BSEP, OATP-A, OATP-C, OATP-D, OATP-E and NTCP gene transcripts in 1st and 3rd trimester human placenta. Placenta 2003; 24(1): 39-44.

  13. Marin JJG, Serrano MA, El-Mir MY, Eleno N, Boyd CA. Bile acid transport by basal membrane vesicles of human term placental trophoblast. Gastroenterology 1990; 99(5): 1431-1438.

  14. Serrano MA, Bayon JE, Pascolo L, Tiribelli C, Ostrow JD, Gonzalez-Gallego J, Marin JJG. Evidence for carrier-mediated transport of unconjugated bilirubin across plasma membrane vesicles from human placental trophoblast. Placenta 2002; 23(7): 527-535.

  15. Suzuki H, Sugiyama Y. Transport of drugs across the hepatic sinusoidal membrane: sinusoidal drug influx and efflux in the liver. Semin Liver Dis 2000; 20(3): 251-263.

  16. Briz O, Serrano MA, Rebollo N, Hagenbuch B, Meier PJ, Koepsell H, Marin JJG. Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum(II) and cis-diammine-bisursodeoxycholate-platinum(II) toward liver cells. Mol Pharmacol 2002; 61(4): 853-860.

  17. Kekuda R, Prasad PD, Wu X, Wang H, Fei YJ, Leibach FH, Ganapathy V. Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J Biol Chem 1998; 273(26): 15971-15979.

  18. Muller M, Mayer R, Hero U, Keppler D. ATP-dependent transport of amphiphilic cations across the hepatocyte canalicular membrane mediated by Mdr1 P-glycoprotein. FEBS Lett 1994; 343(2): 168-172.

  19. Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Roth J, Hofmann AF, et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998; 273(16): 10046-10050.

  20. Jedlitschky G, Leier I, Buchholz U, Hummel-Eisenbeiss J, Burchell B, Keppler D. ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochem J 1997; 327(1): 305-310.

  21. Cui Y, Konig J, Buchholz JK, Spring H, Leier I, Keppler D. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol Pharmacol 1999; 55(5): 929-937.

  22. Imai Y, Asada S, Tsukahara S, Ishikawa E, Tsuruo T, Sugimoto Y. Breast cancer resistance protein exports sulfated estrogens but not free estrogens. Mol Pharmacol. 2003; 64(3): 610-618.

  23. Janvilisri T, Shahi S, Venter H, Balakrishnan L, van Veen HW. Arginine-482 is not essential for transport of antibiotics, primary bile acids and unconjugated sterols by the human breast cancer resistance protein (ABCG2). Biochem J 2005; 385(2): 419-426.

  24. Ogawa K, Suzuki H, Hirohashi T, Ishikawa T, Meier PJ, Hirose K, Akizawa T, et al. Characterization of inducible nature of MRP3 in rat liver. Am J Physiol 2000; 278(3): G438-G446.

  25. Soroka CJ, Lee JM, Azzaroli F, Boyer JL. Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology 2001; 33(4): 783-791.

  26. Donner MG, Keppler D. Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology 2001; 34(2): 351-359.

  27. Vos TA, Hooiveld GJ, Koning H, Childs S, Meijer DK, Moshage H, Jansen PL, et al. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 1998; 28(6): 1637-1644.

  28. Tanaka Y, Kobayashi Y, Gabazza EC, Higuchi K, Kamisako T, Kuroda M, Takeuchi K, et al. Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice. Am J Physiol 2002; 282(4): G656-G662.

  29. Javitt NB. Cholesterol, hydroxycholesterols, and bile acids. Biochem Biophys Res Commun 2002; 292(5): 1147-1153.

  30. Suchy FJ, Bucuvalas JC, Novak DA. Determinants of bile formation during development: Ontogeny of hepatic bile acid metabolism and transport. Semin Liver Dis 1987; 7(2): 77-84.

  31. Monte MJ, Morales AI, Arevalo M, Alvaro I, Macias RI, Marin JJG. Reversible impairment of neonatal hepatobiliary function by maternal cholestasis. Hepatology 1996; 23(5): 1208-1217.

  32. Colombo C, Roda A, Roda E, Buscaglia M, dell’Agnola CA, Filippetti P, Ronchi M, et al. Correlation between fetal and maternal serum bile acid concentrations. Pediatr Res 1985; 19(2): 227-231.

  33. Balistreri WF, A-Kader HH, Setchell KD, Gremse D, Ryckman FC, Schroeder TJ. New methods for assessing liver function in infants and children. Ann Clin Lab Sci 1992; 22(3): 162-174.

  34. Monte MJ, Rodriguez-Bravo T, Macias RI, Bravo P, el-Mir MY, Serrano MA, Lopez-Salva A, et al. Relationship between bile acid transplacental gradients and transport across the fetal-facing plasma membrane of the human trophoblast. Pediatr Res 1995; 38(2): 156-163.

  35. Nakagawa M, Setchell KD. Bile acid metabolism in early life: Studies of amniotic fluid. J Lipid Res 1990; 31(6): 1089-1098.

  36. Knudsen A, Lebech M. Maternal bilirubin, cord bilirubin, and placenta function at delivery and the development of jaundice in mature newborns. Acta Obstet Gynecol Scand 1989; 68(8): 719-724.

  37. Li L, Meier PJ, Ballatori N. Oatp2 mediates bidirectional organic solute transport: a role for intracellular glutathione. Mol Pharmacol 2000; 58(2): 335-340.

  38. Fujiwara K, Adachi H, Nishio T, Unno M, Tokui T, Okabe M, Onogawa T, et al. Identification of thyroid hormone transporters in humans: different molecules are involved in a tissue-specific manner. Endocrinology 2001; 142(5): 2005-2012.

  39. Sato K, Sugawara J, Sato T, Mizutamari H, Suzuki T, Ito A, Mikkaichi T, et al. Expression of organic anion transporting polypeptide E (OATP-E) in human placenta. Placenta 2003; 24(2-3): 144-148.

  40. Cabral DJ, Small DM, Lilly HS, Hamilton JA. Transbilayer movement of bile acids in model membranes. Biochemistry 1987; 26(7): 1801-1804.

  41. Macias RI, Pascual MJ, Bravo A, Alcalde MP, Larena MG, St-Pierre MV, Serrano MA, et al. Effect of maternal cholestasis on bile acid transfer across the placenta-maternal liver tandem. Hepatology 2000; 31(4): 975-983.

  42. Marin JJG, Briz O, Serrano MA. A review on the molecular mechanisms involved in the placental barrier for drugs. Current Drug Deliv 2004; 1: 275-289.

  43. Iioka H, Moriyama I, Hino K, Ichijo M. A study on the mechanism of bile acid transport in the human placenta (the passive transport system of taurocholate across microvillous membrane). Nippon Sanka Fujinka Gakkai Zasshi 1986; 38(6): 837-844.

  44. Dumaswala R, Setchell KD, Moyer MS, Suchy FJ. An anion exchanger mediates bile acid transport across the placental microvillous membrane. Am J Physiol 1993; 264(6): G1016-G1023.

  45. Iioka H, Hisanaga H, Akada S, Shimamoto T, Yamada Y, Sakamoto Y, Moriyama IS, et al. Characterization of human placental activity for transport of taurocholate, using brush border (microvillous) membrane vesicles. Placenta 1993; 14(1): 93-102.

  46. Marin JJG, Bravo P, El-Mir MY, Serrano MA. ATP-dependent bile acid transport across microvillous membrane of human term trophoblast. Am J Physiol 1995; 268(4): G685-G694.

  47. El-Mir MY, Eleno N, Serrano MA, Bravo P, Marin JJG. Bicarbonate-induced activation of taurocholate transport across the basal plasma membrane of the human term trophoblast. Am J Physiol 1991; 260(6): G887-G894.

  48. Serrano MA, Bravo P, El-Mir MY, Marin JJ. Influence of hydroxylation and conjugation in cross-inhibition of bile acid transport across the human trophoblast basal membrane. Biochim Biophys Acta 1993; 1151(1): 28-34.

  49. Bravo P, El-Mir MYA, Serrano MA, Boyd R, Marin JJG. Interaction between cholephilic anions and bile acid transport across basal membrane of human trophoblast. Am J Physiol 1993; 265(2 Pt 1): G242-G250.

  50. Serrano MA, Macias RI, Vallejo M, Briz O, Bravo A, Pascual MJ, St-Pierre MV, et al. Effect of ursodeoxycholic acid on the impairment induced by maternal cholestasis in the rat placenta-maternal liver tandem excretory pathway. J Pharmacol Exp Therap 2003; 305(2): 515-524.

  51. St-Pierre MV, Hagenbuch B, Ugele B, Meier PJ, Stallmach T. Characterization of an organic anion transporting polypeptide OATP B in human placenta. J Clin Endocrin Metab 2002; 87(4): 1856-1863.

  52. Nishio T, Adachi H, Nakagomi R, Tokui T, Sato E, Tanemoto M, Fujiwara K, et al. Molecular identification of a rat novel organic anion transporter moat1, which transports prostaglandin D(2), leukotriene C(4), and taurocholate. Biochem Biophys Res Commun 2000; 275(3): 831-838.

  53. Bravo P, Marin JJG, Beveridge MJ, Novak DA. Reconstitution and characterization of ATP-dependent bile acid transport in human and rat placenta. Biochem J 1995; 311(2): 479-485.

  54. Young AM, Allen CE, Audus KL. Efflux transporters of the human placenta. Adv Drug Deliv Rev 2003; 55(1): 125-132.

  55. St-Pierre MV, Serrano MA, Macias RI, Dubs U, Hoechli M, Lauper U, Meier PJ, et al. Expression of members of the multidrug resistance protein family in human term placenta. Am J Physiol 2000; 279(4): R1495-R1503.

  56. Rius M, Nies AT, Hummel-Eisenbeiss J, Jedlitschky G, Keppler D. Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 2003; 38(2): 374-84.

  57. Leazer TM, Klaassen CD. The presence of xenobiotic transporters in rat placenta. Drug Metab Dispos 2003; 31(2): 153-167.

  58. St-Pierre MV, Serrano MA, Lauper U, Marin JJG, Meier PJ. Identification of bile salt transporters in human and rat placenta. (Abstract) Placenta 1999; 20: A62.

  59. Allikmets R, Schriml LM, Hutchinson A, Romano-Spica V, Dean M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res 1998; 58(23): 5337-5339.

  60. Galbraith R. Heme oxygenase: who needs it? Proc Soc Exp Biol Med 1999; 222(3): 299-305.

  61. Ryter SW, Tyrrell RM. The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties. Free Radic Biol Med 2000; 28(2): 289-309.

  62. Lyall F, Barber A, Myatt L, Bulmer JN, Robson SC. Hemeoxygenase expression in human placenta and placental bed implies a role in regulation of trophoblast invasion and placental function. FASEB J 2000; 14(1): 208-219.

  63. McCoubrey WK, Cooklis MA, Maines MD. The structure, organization and differential expression of the rat gene encoding biliverdin reductase. Gene 1995; 160(2): 235-240.

  64. McDonagh AF, Palma LA, Schmid R. Reduction of biliverdin and placental transfer of bilirubin and biliverdin in the pregnant guinea pig. Biochem J 1981; 194(1): 273-282.

  65. Stollman YR, Gartner U, Theilmann L, Ohmi N, Wolkoff AW. Hepatic bilirubin uptake in the isolated perfused rat liver is not facilitated by albumin binding. J Clin Inves; 1983 72(2): 718-723.

  66. Bosma PJ, Seppen J, Goldhoorn B, Bakker C, Oude Elferink RP, Chowdhury JR, Chowdhury NR, et al. Bilirubin UDP-glucuronos yltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 1994; 269(27): 17960-17964.

  67. Keppler D, Kamisako T, Leier I, Cui Y, Nies AT, Tsujii H, Konig J. Localization, substrate specificity, and drug resistance conferred by conjugate export pumps of the MRP family. Adv Enzyme Regul 2000; 40: 339-349.

  68. Terrenato L, Bertilaccio C, Spinelli P, Colombo B. The switch from haemoglobin F to A: the time course of qualitative and quantitative variations of haemoglobins after birth. Br J Haematol 1981; 47(1): 31-41.

  69. Ogita S, Shimamoto T, Ohnishi M, Kamei T, Noma H, Ishiko O, Ando T, et al. Hemolytic pattern of erythrocytes in the newborn measured by the coil planet centrifuge system and its relationship to neonatal jaundice. Eur J Pediatr 1978; 127(2): 67-73.

  70. Kawade N, Onishi S. The prenatal and postnatal development of UDP-glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in the human liver. Biochem J 1981; 196(1): 257-260.

  71. McDonagh AF. Turning green to gold. Nat Struct Biol 2001; 8(3): 198-200.

  72. Schenker S, Dawber NH, Schmid R. Bilirubin metabolism in the fetus. J Clin Invest 1964; 43: 32-39.

  73. Bernstein RB, Novy MJ, Piasecki GJ, Lester R, Jackson BT. Bilirubin metabolism in the fetus. J Clin Invest 1969; 48(9): 1678-1688.

  74. Lester R, Behrman RE, Lucey JF. Transfer of bilirubin-C across monkey placenta. Pediatrics 1963; 32: 416-419.

  75. Bashore RA, Smith F, Schenker S. Placental transfer and disposition of bilirubin in the pregnant monkey. Am J Obstet Gynecol 1969; 103(7): 950-958.

  76. Briz O, Macias RI, Serrano MA, Gonzalez-Gallego J, Bayon JE, Marin JJG. Excretion of foetal bilirubin by the rat placenta-maternal liver tandem. Placenta 2003b; 24(5): 462-472.

  77. Brodie BB, Axelrod J, Soberman R, Levy BB. The estimation of antipyrine in biological materials. J Biol Chem 1949; 179: 25-29.

  78. Weiner CP. Human fetal bilirubin levels and fetal hemolytic disease. Am J Obstet Gynecol 1992; 166(5): 1449-1454.

  79. Pascolo L, Fernetti C, Garcia-Mediavilla MV, Ostrow JD, Tiribelli C. Mechanisms for the transport of unconjugated bilirubin in human trophoblastic BeWo cells. FEBS Lett 2001; 495(1-2): 94-99.

  80. Lammert F, Marschall HU, Matern S. Intrahepatic cholestasis of pregnancy. Curr Treat Options Gastroenterol 2003; 6(2): 123-132.

  81. Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology 2004; 40(2): 467-474.

  82. Serrano MA, Brites D, Larena MG, Monte MJ, Bravo MP, Oliveira N, Marin JJG. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta. J Hepatol 1998; 28(5): 829-839.

  83. El-Mir MY, Monte MJ, Morales AI, Arevalo M, Serrano MA, Marin JJG. Effect of maternal cholestasis on biliary lipid and bile acid secretion in the infant rat. Hepatology 1997; 26(3): 527-536.

  84. Monte MJ, Villanueva GR, Macias RI, Vazquez DJ, Toledo M, Dominguez M, Marin JJG. Effect of maternal obstructive cholestasis during pregnancy on the biliary transport of horseradish peroxidase in the rat offspring. Clin Sci 2003; 105(3): 347-353.

  85. Arrese M, Trauner M, Ananthanarayanan M, Boyer JL, Suchy FJ. Maternal cholestasis does not affect the ontogenic pattern of expression of the Na+/taurocholate cotransporting polypeptide (ntcp) in the fetal and neonatal rat liver. Hepatology 1998; 28(3): 789-795.

  86. Macias RI, Serrano MA, Monte MJ, Jimenez S, Hernandez B, Marin JJG. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis. J Pharmacol Exp Ther 2005; 312(2): 751-758.

  87. Serrano MA, Monte MJ, Martinez-Diez MC, Marin JJG. Effect of maternal cholestasis on the kinetics of bile acid transport across the canalicular membrane of infant rat livers. Int J Exp Pathol 1997; 78(6): 383-390.

  88. Attili AF, Angelico M, Cantafora A, Alvaro D, Capocaccia L. Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids. Med Hypotheses 1986; 19(1): 57-69.

  89. Perez MJ, Macias RI, Marin JJG. Maternal cholestasis induces placental oxidative stress and apoptosis. Protective effect of ursodeoxycholic acid. Placenta (in press) 2005a.

  90. Perez MJ, Macias RI, Duran C, Monte MJ, Gonzalez-Buitrago JM, Marin JJG. Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid. J Hepatol (in press) 2005b.




2020     |     www.medigraphic.com